Related Experiment Video

Updated: Feb 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.1K

Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure

Omar M Aldaas1, Chaitanya L Malladi1, Jonathan C Hsu1

  • 1Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego, California.

The American Journal of Cardiology
|October 25, 2018
PubMed

Insights

Catheter ablation effectively treats atrial fibrillation (AF) in heart failure (HF) patients, improving quality of life and reducing hospitalizations. This procedure offers a promising alternative for managing these common cardiovascular conditions.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Atrial fibrillation (AF) and heart failure (HF) are prevalent cardiovascular diseases with significant impact on morbidity, mortality, and healthcare costs.
  • Coexistence of AF and HF exacerbates patient outcomes, yet consensus treatment strategies remain unclear.
  • Catheter ablation is a recognized treatment for AF in patients with normal cardiac function, with emerging data for those with HF.

Purpose of the Study:

  • To review the impact of catheter ablation for AF in patients with heart failure.
  • To evaluate effects on sinus rhythm maintenance, left ventricular ejection fraction, exercise capacity, quality of life, hospitalizations, and mortality.
  • To discuss data for both HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).

Main Methods:

  • Systematic review of studies on catheter ablation of AF in patients with HF.
  • Analysis of outcomes including rhythm control, cardiac function, functional capacity, and survival.
  • Inclusion of data pertaining to both HFrEF and HFpEF populations.

Main Results:

  • Catheter ablation demonstrates efficacy in maintaining sinus rhythm in AF patients with HF.
  • Studies indicate potential improvements in left ventricular ejection fraction, exercise capacity, and quality of life post-ablation.
  • Evidence suggests a reduction in hospitalization rates and possibly mortality in this patient group.

Conclusions:

  • Catheter ablation is a viable rhythm control strategy for symptomatic AF in patients with HF.
  • The procedure may offer significant benefits beyond rhythm control, impacting cardiac function and patient outcomes.
  • Further research is warranted to solidify treatment guidelines for AF ablation in diverse HF populations.

More Related Videos

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.2K
Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

14.4K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971